Well Referenced

Tag: IBD

From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting

This review highlights the utility of fecal calprotectin (FC) as a non-invasive biomarker for managing inflammatory bowel diseases (IBD). It describes FC’s role in differentiating IBD from irritable bowel syndrome (IBS), monitoring disease activity, predicting relapses, and evaluating treatment response. Although FC levels correlate well with mucosal healing and histology,

Read More »
June 26, 2025 No Comments

Neuroprotective actions of methylene blue and its derivatives

This article examines the clinical pharmacology of curcumin, a compound found in turmeric, for treating inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. It discusses curcumin’s potent anti-inflammatory, antioxidant, and immunomodulatory effects that help reduce inflammation and promote healing in IBD patients. Clinical studies indicate a 40-50% improvement

Read More »
June 26, 2025 No Comments

Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease

The article titled “Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease,” published in the American Journal of Gastroenterology (1998), examined the relationship between inflammatory markers and serum levels of adrenal hormones (DHEAS and cortisol) in patients with chronic

Read More »
June 26, 2025 No Comments